Novel Pyrrolo[1,2-a]Pyrazines (TSPO Ligands) with Anxiolytic Activity Dependent on Neurosteroid Biosynthesis
- 17 November 2016
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Chemistry Journal
- Vol. 50 (8), 501-504
- https://doi.org/10.1007/s11094-016-1476-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamidesBioorganic & Medicinal Chemistry, 2015
- Progesterone and its metabolites as therapeutic targets in psychiatric disordersEmerging Therapeutic Targets, 2014
- Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disordersNature Reviews Drug Discovery, 2010
- Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2010
- Endogenous and synthetic neurosteroids in treatment of Niemann–Pick Type C diseaseBrain Research Reviews, 2008
- Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sitesNature, 2006
- Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionTrends in Pharmacological Sciences, 2006
- The effects of repeated doses of ethanol on exploration and its habituationPsychopharmacology, 1987
- Trilostane, an orally active inhibitor of steroid biosynthesisSteroids, 1978
- Anesthetic Effect of Steroid Hormones.Experimental Biology and Medicine, 1941